BNET Industries

Patheon Inc.

PTI is in the Pharma Industry

Market Cap:$1.2B
Last Fiscal Year Sales:$712.1M
  • Public
  • CA
Dow Jones Description

Prescription & Over-the-Counter Drugs Packaging & Mfr

CEO & General Counsel
Ricardo Trecoce
Number of Employees 4,650
Contact Information

7070 Mississauga Road Suite 350

Mississauga, Ontario

www.patheon.com

(905) 821-4001

NAICS Code Drugs and Druggists' Sundries Merchant Wholesalers: 424210

Recent Events

  • Patheon cancels Dec. 15 shareholder meeting after request withdrawn

    12/11/09 - Merger / Acquisition - View Story

  • Patheon, JLL settle legal battle

    11/30/09 - Merger / Acquisition - View Story

  • Patheon, Inc. announces the appointment of Francisco R. Negron as Vice President and general manager...

    11/18/09 - Mgmt. Change Entering - General Manager - View Story

  • Week of Nov. 23, 2009: Pfizer Collaborates to Fight Neglected Diseases; Patheon Names VP of...

    11/24/09 - Mgmt. Change Entering - Vice President - View Story

  • Patheon, Inc. adds two key industry leaders to its pharmaceutical development services business

    11/09/09 - Mgmt. Change Entering - Director - View Story

  • Patheon girds for battle

    10/31/09 - Lawsuit Filed - View Story

  • Week of Oct. 19, 2009: Lonza Drops Bid for Patheon; Peregrine Appoints Head of Regulatory...

    10/21/09 - Merger / Acquisition - View Story

  • UPDATE 1-Lonza cuts full-year target, sees more volatility

    10/29/09 - Merger / Acquisition - View Story

  • QRxPharma Pty Ltd. Inks Deal with Patheon (PTI.TO) for the Manufacture of MoxDuoTMCR Company on...

    10/13/09 - Joint Venture / Alliance - View Story

  • Lonza Group Ltd. JOBS Announces Withdrawal of $460 Million Bid for Patheon (PTI.TO)

    10/21/09 - Merger / Acquisition - View Story

  • QRxPharma Inks Deal With Patheon to Manufacture Pain Drug

    10/12/09 - Joint Venture / Alliance - View Story

  • Patheon Signs Agreement with Zycus for Strategic Sourcing Solution

    10/12/09 - Joint Venture / Alliance - View Story

  • Talks extended in Swiss company's takeover of Toronto-based Patheon

    9/28/09 - Merger / Acquisition - View Story

News & Analysis

patheon inc. - All News and Analysis

  • Will Lonza's $460m Patheon offer trigger bidding war?

    BNET - 2009-08-24

    Lonza's bid, reported by Outsourcing-pharma on Friday, betters the unsolicited $2 per share offer tabled by JLL in March and is a "more attractive alternative," according to Paul Currie, chair of Patheon's special committee of independent directors. Currie added that: "The Lonza's proposal would provide an excellent opportunity to secure...

    Tags: takeover

  • New Analyst Reports for PATHEON INC, ABITEX RESOURCES INC, UNIVERSAL ENERGY GROUP LTD, and OSISKO EXPLORATION LTD

    - 2008-06-12

    MaybachFinancial.com is one of the fastest growing independent and unbiased research firms in the world. Through our numerous partnerships with many of the top investment minds in the world, we provide research on companies making a move in the markets. Investors seeking genuine analyst opinions on their investments for PATHEON...

    Tags: Patheon Inc.

  • Patheon Inc.(INDUSTRIAL Briefs)

    - 2008-04-01

    Patheon Inc. has appointed Terry Novak as president of North American Operations and chief marketing officer.

    Tags: Patheon Inc.

  • Global Market Progressive Review on Patheon.

    - 2008-03-07

    M2 PRESSWIRE-7 March 2008-The SI Report: Global Market Progressive Review on PatheonC1994-2008 M2 COMMUNICATIONS LTD RDATE:07032008 Streetinvesting.com has now resumed our progressive review of Patheon (TSX:PTI) after it traded down 5% Friday, early in the morning with average volume....

    Tags: Patheon Inc.

  • Senopsys and Patheon Collaborate to Develop Palatable Drug Products

    - 2007-06-19

    SAUGUS, Mass. -- Senopsys LLC, a specialty pharmaceutical services company, announced today that it has signed a collaboration agreement with Patheon Inc. (TSX:PTI), a leading global provider of drug development and manufacturing services, to accelerate the development of palatable drug products. Through this collaboration, Senopsys clients will have access to...

    Tags: Patheon Inc.

Decision Makers

Name (plus bio) Position
Ricardo Trecoce CEO & General Counsel
Wesley P. Wheeler Chief Executive Officer
Clive V. Bennett President, USA
Shabbir T. Anik President, Global Pharmaceutical Dev Services & Chief Scientific Officer
Terry Novak President, North American Operations and Chief Marketing Officer
John H. Bell Cfo
Rodger Roden CFO & Senior Vice President, Finance
Steven M. Liberty Senior Vice President, Operations
Tom L. Ferguson Senior Vice President, Global IT
Andrew Kelley Vice President, Operations, Uk
Antonella Mancuso Vice President, Operations, Italy
Colin M. Minchom Vice President, Pharmaceutical Dev Services
Ian Jones Vice President, Finance
Jonathan Arnold Vice President, Global Supply Chain
Murray Snedden Treasurer & Vice President
Nicholas M. Dowd Controller & Vice President
Norman Barras Vice President, Pharmaceutical Dev Services
Ronald R. Schallick Vice President, Operations, Cincinnati
Roy J. Wieschkowski Vice President, Hr
Shelley Jourard Director, Corp Communications
Mohamed Bhamani
Pranav Pandya Development Engineer
E James Arnett Director
George L. Ploder Director
Nick A. Dipietro Director

Board of Directors

Name (plus bio) Position
Peter A.W. Green Chairman
Derek J. Watchorn Board of Directors
Gregory C. Wilkins Board of Directors
Joaquin B. Viso Board of Directors
Robert C. Tedford Board of Directors

Organization Position Status
Patheon, Inc. CEO & General Counsel Current
Patheon, Inc. Board of Directors Current
Patheon, Inc. General Counsel, Senior Vice President, Admin & Secretary Former

Organization Position Status
Patheon, Inc. Chief Executive Officer Current
Valeant Pharmaceuticals International President, Global Commercial Development, North America Former

Organization Position Status
Patheon, Inc. President, USA Current

Organization Position Status
Patheon, Inc. President, Global Pharmaceutical Dev Services & Chief Scientific Officer Current
Pharmquest Corporation Board of Directors Current
Patheon, Inc. Vice President of Global Pharmaceutical Development Former
Santa Clara University M.B.A. Former

Organization Position Status
Patheon, Inc. President, North American Operations and Chief Marketing Officer Current
DSM Pharmaceuticals President Former

Organization Position Status
Patheon, Inc. Cfo Current
University of Manitoba Bachelor of Commerce Degree Former

Organization Position Status
Patheon, Inc. CFO & Senior Vice President, Finance Current

Organization Position Status
Patheon, Inc. Senior Vice President, Operations Current
AstraZeneca Pharmaceuticals LP General Manager Former
Eli Lilly and Company Former
Richard Ivey School of Business, The University of Western Ontario Mba Former
The University of Western Ontario Bachelor of Engineering Science Former

Organization Position Status
Patheon, Inc. Senior Vice President, Global IT Current

Organization Position Status
Patheon, Inc. Vice President, Operations, Uk Current
Cardinal Health, Inc. Former
Henley Management College Master of Business Administration Former
University of Birmingham Bachelor of Science Degree In Chemical Engineering Former

Organization Position Status
Patheon, Inc. Vice President, Operations, Italy Current
Patheon, Inc. Production Manager Former
Bristol-Myers Squibb Company Former
Patheon, Inc. Director Former
University of Rome Former

Organization Position Status
Patheon, Inc. Vice President, Pharmaceutical Dev Services Current
Integrity Biosolution Current
Cerebrus Incorporated Former
Patheon, Inc. Director Former

Organization Position Status
Patheon, Inc. Vice President, Finance Current
Patheon, Inc. Finance Director Former
Unipart Group of Companies Limited Financial Controller Former

Organization Position Status
Patheon, Inc. Vice President, Global Supply Chain Current
Patheon, Inc. Business Manager Former
Cardinal Health, Inc. Former
Patheon, Inc. Director Former
University of Newcastle upon Tyne Bachelor of Science Former

Organization Position Status
Patheon, Inc. Treasurer & Vice President Current
Marathon Realty Former
Oxford Properties Group Treasurer Former

Organization Position Status
Patheon, Inc. Controller & Vice President Current
Patheon, Inc. Head of Corporate Development Former
University of Nottingham Bachelor of Arts (Honours) In Economics Former

Organization Position Status
Patheon, Inc. Vice President, Pharmaceutical Dev Services Current
Norgine International Limited Scientific Director Former
Patheon, Inc. Group Director Former
PA Consulting Group Former
University of Hertfordshire Master of Science In Biochemical Pharmacology Former

Organization Position Status
Patheon, Inc. Vice President, Operations, Cincinnati Current
Patheon, Inc. Site Director Former
Aventis Pharmaceuticals Inc Site Director Former
University of Cincinnati Bachelor of Science In Mechanical Engineering and An Mba Former

Organization Position Status
Patheon, Inc. Vice President, Hr Current
Cascade Corporation Current
Corporate Human Resources, Inc Senior Director Former
ICI Paints Former
Patheon, Inc. Director Former
Wilfrid Laurier University Business Administration (Hons.) Former

Organization Position Status
Patheon, Inc. Director, Corp Communications Current

Organization Position Status
Focus Business Consulting First Director of Finance and Administration Current
Patheon, Inc. Current
Mezzanine Business Consulting Current
Focus Business Consulting One of the Founding Members Former
McMaster University Former
Wilfrid Laurier University Bachelor of Arts Degree In Political Science Former

During his nine years in the pharmaceutical industry, Pranav has gained significant experience in the formulation development and process development of various kinds of dosage forms within the industry. Pranav was a Senior Process Specialist at Skye Pharma Canada. He developed formulations and the processes for several NDA candidates, and one of which is already launched in the market. The Skye Pharma Canada utilized their IDD-D and IDD-P technologies for improving the bioavailability of the suitable drug candidates and Pranav gained extensive experience in designing drug formulation from early phase development to commercial production. Pranav was a Manager of Process Development at Labopharm Inc.. He gained extensive experience in designing the manufacturing processes for drug candidates with control release application. Labopharm uses their Contramid technology for extending the release of the drug molecules. One of the drug candidates that Pranav had worked for over two years at Labopharm got its approval in Europe and is also submitted for NDA in United States. Pranav was also designated as a Project Team Leader and led a team of formulation scientists, analytical chemists and clinical scientist for a developing controlled release formulation. In his current role as Process Development Engineer at Patheon Inc., Pranav takes care of developing manufacturing process of different kinds of drug formulations which often involves solid and semi-solid dosage forms. Pranav is also a part-time instructor and program coordinator of Industrial Pharmaceutical Technology course at Seneca college-Toronto. He is currently responsible for the pharmaceutical manufacturing methods (PFT 501) and Product formulation (PFT 907) at Seneca (York university campus).

Organization Position Status
Patheon, Inc. Development Engineer Current
Labopharm Inc. Manager Former

Organization Position Status
Patheon, Inc. Chairman Current
Patheon, Inc. Board of Directors Current

Organization Position Status
Patheon, Inc. Board of Directors Current

Organization Position Status
Kik Los Angeles Q.C. Chair Current
Patheon, Inc. Director Current
Mol-Son Chief Executive Officer Former
Mol-Son President Former
Mol-Son Board of Directors Former
Mol-Son Member Former

Organization Position Status
Bennett Environmental, Inc. Director Current
Patheon, Inc. Director Current
Bracknell President Former
Ernst & Whinney Former

Organization Position Status
Patheon, Inc. Board of Directors Current
Barrick Gold Corporation Executive Vice Chairman Current
World Gold Council Chairman Former
TrizecHahn Corporation President & Chief Operating Officer Former
Barrick Gold Corporation Chief Operating Officer Former
Concordia University Bachelor of Commerce Degree Former

Organization Position Status
Patheon, Inc. Board of Directors Current

Mr. DiPietro is President and Chief Operating Officer of Patheon Inc., and was recently appointed to the Office of the Chief Executive Officer. He joined a predecessor corporation of Patheon as Operations Manager in 1982, becoming President in 1989. He was appointed to his current position in 1996. Mr. DiPietro holds an Honours B.Sc. in Biochemistry and an MBA from McMaster University. He has been a Director of Patheon since 1993.

Organization Position Status
Patheon, Inc. Director Current
Patheon, Inc. President and Chief Operating Officer Former
Patheon Niagara Region Operations President Former
Patheon, Inc. Operations Manager Former
McMaster University Mba Former

Organization Position Status
Patheon, Inc. Board of Directors Current
Patheon, Inc. CEO Former

Executive News

  • Patheon signs facilities management agreement with EMCOR Group, Inc. subsidiary

    Pharma Live - 7/21/09 - View Story

  • Patheon Signs Facilities Management Agreement With Emcor Group, Inc. Subsidiary

    Bioresearch Online - 7/21/09 - View Story

  • Patheon Announces Appointment of New Chairman of the Board

    Pharma Live - 7/19/09 - View Story

  • Patheon signs management agreement with Emcor

    Stockwatch - 7/16/09 - View Story

  • Patheon signs facilities management agreement with EMCOR Group, Inc. subsidiary

    Yahoo! Canada - 7/16/09 - View Story

  • Patheon Announces Appointment of New Chairman of the Board

    Canada NewsWire - 7/16/09 - View Story

advertisement
PTI $19.69 +0.13 (0.66% )
Volume 40,835
Shares Outstanding 64.4M
Market Cap 1.2B
Year High 21.93
Year Low 4.25
Earnings Per Share 1.49
P/E Ratio 13.2148
Dividend 0.1245
Yield 0.6323
IndustryTop Rated

Brought to you by CBS MoneyWatch.com

advertisement
Presented by American Express